ArticleNeoplasia (New York, N.Y.)2014

Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.

Nagireddy Putluri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.